Cyteir Therapeutics Inc. (CYT)
NASDAQ: CYT
· Real-Time Price · USD
3.02
-0.07 (-2.27%)
At close: Mar 15, 2024, 9:00 PM
Cyteir Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -7.24 | -2.76 | -1.4 | -1.97 | -1.64 | -2.19 | -2.36 | -8.45 | -13.14 | -16.47 | -20.5 |
PEG Ratio | 0.12 | 0.11 | -0.03 | 0.07 | 0.11 | 0.15 | -0.13 | -2.79 | -4.21 | -0.31 | 4.51 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.82 | 0.73 | 0.48 | 0.40 | 0.44 | 0.64 | 0.76 | 2.13 | 3.11 | 3.84 | -11 |
P/FCF Ratio | -22.46 | -22.4 | -6.37 | -8.09 | -5.39 | -9.6 | -10.75 | -39.48 | -46.18 | -102.97 | -91.53 |
P/OCF Ratio | -22.46 | -22.4 | -6.37 | -8.44 | -5.4 | -9.7 | -10.92 | -41.54 | -47.59 | -104.62 | -94.09 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | n/a | n/a | n/a | n/a |
Quick Ratio | 21.89 | 20.37 | 35.00 | 28.07 | 27.05 | 19.95 | 19.77 | 25.71 | 27.12 | 26.91 | 20.02 |
Current Ratio | 21.89 | 20.35 | 34.94 | 28.07 | 27.05 | 19.95 | 19.77 | 25.71 | 27.12 | 26.91 | 20.02 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.03 | -0.07 | -0.09 | -0.05 | -0.07 | -0.07 | -0.08 | -0.06 | -0.06 | -0.06 | 0.13 |
Return on Assets | -0.03 | -0.06 | -0.08 | -0.05 | -0.06 | -0.07 | -0.08 | -0.06 | -0.06 | -0.06 | -0.08 |
Return on Invested Capital | -0.04 | -0.08 | -0.09 | -0.06 | -0.07 | -0.07 | -0.08 | -0.06 | -0.06 | -0.06 | -0.09 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |